Ensysce Biosciences Posts Q4 Earnings Beat Despite Revenue Miss
Ensysce Biosciences reported fourth-quarter earnings that surpassed analyst expectations by $0.51 per share, though quarterly revenue fell short of consensus estimates.
PA
Priya Anand · Equities & Earnings Desk · 17 Aug 2026 · 1 min read
Ensysce Biosciences released its financial results for the quarter, outperforming analyst expectations on the bottom line while missing revenue forecasts.
The company posted an earnings beat of $0.51 per share compared to consensus estimates. However, top-line revenue for the period came in below expectations.
This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
PA
Written by
Priya Anand
Equities & Earnings Desk
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →